<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
    <channel>
        <title>TrialSiteNews Feed</title>
        <link>https://trialsitenews.com</link>
        <description>This is a feed of all latest posts on TrialSiteNews</description>
        <lastBuildDate>Fri, 02 Oct 2026 05:44:35 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>NextJS + feed package</generator>
        <language>en</language>
        <item>
            <title><![CDATA[Pfizer’s ALC-0315 Under the Microscope: Chemist Flags Potential Metabolite Error in Comirnaty Regulatory Record]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/pfizers-alc-0315-under-the-microscope-chemist-flags-potential-metabolite-error-in-comirnaty-regulatory-record-44d43eb2</link>
            <guid>https://trialsitenews.com/p/trialsitenews/pfizers-alc-0315-under-the-microscope-chemist-flags-potential-metabolite-error-in-comirnaty-regulatory-record-44d43eb2</guid>
            <pubDate>Fri, 02 Oct 2026 01:39:38 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/pfizers-alc-0315-under-the-microscope-chemist-flags-potential-metabolite-error-in-comirnaty-regulatory-record-44d43eb2" title="Pfizer’s ALC-0315 Under the Microscope: Chemist Flags Potential Metabolite Error in Comirnaty Regulatory Record" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/3ce82336-4e9b-4b76-ce26-e87baeb17900/public" loading="lazy" /></a> Pfizer’s ALC-0315 Under the Microscope: Chemist Flags Potential Metabolite Error in Comirnaty Regulatory Record]]></description>
        </item>
        <item>
            <title><![CDATA[Florida Sues Pfizer and CEO Albert Bourla: Did COVID-19 Vaccine Marketing Cross the Line?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/florida-sues-pfizer-and-ceo-albert-bourla-did-covid-19-vaccine-marketing-cross-the-line-84c99087</link>
            <guid>https://trialsitenews.com/p/trialsitenews/florida-sues-pfizer-and-ceo-albert-bourla-did-covid-19-vaccine-marketing-cross-the-line-84c99087</guid>
            <pubDate>Fri, 02 Oct 2026 01:35:37 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/florida-sues-pfizer-and-ceo-albert-bourla-did-covid-19-vaccine-marketing-cross-the-line-84c99087" title="Florida Sues Pfizer and CEO Albert Bourla: Did COVID-19 Vaccine Marketing Cross the Line?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/6fc2105d-9b7d-4978-42c4-700fd5788000/public" loading="lazy" /></a> Florida Sues Pfizer and CEO Albert Bourla: Did COVID-19 Vaccine Marketing Cross the Line?]]></description>
        </item>
        <item>
            <title><![CDATA[UC Davis Scientist Lands $1.6 Million NSF Award to Investigate the Body’s Hidden ‘Sixth Sense’]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/uc-davis-scientist-lands-1.6-million-nsf-award-to-investigate-the-bodys-hidden-sixth-sense-ea07c733</link>
            <guid>https://trialsitenews.com/p/trialsitenews/uc-davis-scientist-lands-1.6-million-nsf-award-to-investigate-the-bodys-hidden-sixth-sense-ea07c733</guid>
            <pubDate>Thu, 01 Oct 2026 18:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/uc-davis-scientist-lands-1.6-million-nsf-award-to-investigate-the-bodys-hidden-sixth-sense-ea07c733" title="UC Davis Scientist Lands $1.6 Million NSF Award to Investigate the Body’s Hidden ‘Sixth Sense’" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/501602cd-5ce9-4e84-73e7-648d6cd57d00/public" loading="lazy" /></a> UC Davis Scientist Lands $1.6 Million NSF Award to Investigate the Body’s Hidden ‘Sixth Sense’]]></description>
        </item>
        <item>
            <title><![CDATA[$5.7 Million NIH Diabetes Study Asks a Better Question: Why Doesn’t Body Size Predict Insulin Resistance?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/5.7-million-nih-diabetes-study-asks-a-better-question-why-doesnt-body-size-predict-insulin-resistance-da64bb14</link>
            <guid>https://trialsitenews.com/p/trialsitenews/5.7-million-nih-diabetes-study-asks-a-better-question-why-doesnt-body-size-predict-insulin-resistance-da64bb14</guid>
            <pubDate>Thu, 01 Oct 2026 17:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/5.7-million-nih-diabetes-study-asks-a-better-question-why-doesnt-body-size-predict-insulin-resistance-da64bb14" title="$5.7 Million NIH Diabetes Study Asks a Better Question: Why Doesn’t Body Size Predict Insulin Resistance?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/f3e3223a-b21f-4ebd-09a8-7d885dd95400/public" loading="lazy" /></a> $5.7 Million NIH Diabetes Study Asks a Better Question: Why Doesn’t Body Size Predict Insulin Resistance?]]></description>
        </item>
        <item>
            <title><![CDATA[Retatrutide Delivers Nearly 19% Weight Loss in Type 2 Diabetes—A Powerful Phase 3 Result With Important Caveats]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/retatrutide-delivers-nearly-19-weight-loss-in-type-2-diabetesa-powerful-phase-3-result-with-important-caveats-7a8bad1b</link>
            <guid>https://trialsitenews.com/p/trialsitenews/retatrutide-delivers-nearly-19-weight-loss-in-type-2-diabetesa-powerful-phase-3-result-with-important-caveats-7a8bad1b</guid>
            <pubDate>Thu, 01 Oct 2026 16:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/retatrutide-delivers-nearly-19-weight-loss-in-type-2-diabetesa-powerful-phase-3-result-with-important-caveats-7a8bad1b" title="Retatrutide Delivers Nearly 19% Weight Loss in Type 2 Diabetes—A Powerful Phase 3 Result With Important Caveats" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/efcd0b69-ecf2-4abc-af2d-ffbcee149700/public" loading="lazy" /></a> Retatrutide Delivers Nearly 19% Weight Loss in Type 2 Diabetes—A Powerful Phase 3 Result With Important Caveats]]></description>
        </item>
        <item>
            <title><![CDATA[Gut Microbiome May Shape Vaccine Response—but Scientists Warn Personalized Vaccination Is Not Ready]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/gut-microbiome-may-shape-vaccine-responsebut-scientists-warn-personalized-vaccination-is-not-ready-7919f794</link>
            <guid>https://trialsitenews.com/p/trialsitenews/gut-microbiome-may-shape-vaccine-responsebut-scientists-warn-personalized-vaccination-is-not-ready-7919f794</guid>
            <pubDate>Thu, 01 Oct 2026 15:30:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/gut-microbiome-may-shape-vaccine-responsebut-scientists-warn-personalized-vaccination-is-not-ready-7919f794" title="Gut Microbiome May Shape Vaccine Response—but Scientists Warn Personalized Vaccination Is Not Ready" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/5dd064a2-4b8b-4e32-57a1-1a19801f7700/public" loading="lazy" /></a> Gut Microbiome May Shape Vaccine Response—but Scientists Warn Personalized Vaccination Is Not Ready]]></description>
        </item>
        <item>
            <title><![CDATA[Most U.S. Counties Have No Kidney Cancer Trial: Study Finds Access Favors Less Vulnerable Communities]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/most-u.s.-counties-have-no-kidney-cancer-trial-study-finds-access-favors-less-vulnerable-communities-70900638</link>
            <guid>https://trialsitenews.com/p/trialsitenews/most-u.s.-counties-have-no-kidney-cancer-trial-study-finds-access-favors-less-vulnerable-communities-70900638</guid>
            <pubDate>Thu, 01 Oct 2026 15:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/most-u.s.-counties-have-no-kidney-cancer-trial-study-finds-access-favors-less-vulnerable-communities-70900638" title="Most U.S. Counties Have No Kidney Cancer Trial: Study Finds Access Favors Less Vulnerable Communities" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/37b44d98-80ac-4b57-1300-a771c69ce600/public" loading="lazy" /></a> Most U.S. Counties Have No Kidney Cancer Trial: Study Finds Access Favors Less Vulnerable Communities]]></description>
        </item>
        <item>
            <title><![CDATA[A Simple Video Helped Recruit Alzheimer’s Trial Participants—Could Demystifying Research Solve a Bigger Enrollment Problem?]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/a-simple-video-helped-recruit-alzheimers-trial-participantscould-demystifying-research-solve-a-bigger-enrollment-problem-811c5f4b</link>
            <guid>https://trialsitenews.com/p/trialsitenews/a-simple-video-helped-recruit-alzheimers-trial-participantscould-demystifying-research-solve-a-bigger-enrollment-problem-811c5f4b</guid>
            <pubDate>Thu, 01 Oct 2026 14:00:01 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/a-simple-video-helped-recruit-alzheimers-trial-participantscould-demystifying-research-solve-a-bigger-enrollment-problem-811c5f4b" title="A Simple Video Helped Recruit Alzheimer’s Trial Participants—Could Demystifying Research Solve a Bigger Enrollment Problem?" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/6392f162-c5c9-46ad-d0d9-7b2940482d00/public" loading="lazy" /></a> A Simple Video Helped Recruit Alzheimer’s Trial Participants—Could Demystifying Research Solve a Bigger Enrollment Problem?]]></description>
        </item>
        <item>
            <title><![CDATA[Vaccines or Murder? The Andrea Shaw Case Puts Medical-Freedom Advocacy—and the Media—on Trial]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/vaccines-or-murder-the-andrea-shaw-case-puts-medical-freedom-advocacyand-the-mediaon-trial-442e5a50</link>
            <guid>https://trialsitenews.com/p/trialsitenews/vaccines-or-murder-the-andrea-shaw-case-puts-medical-freedom-advocacyand-the-mediaon-trial-442e5a50</guid>
            <pubDate>Thu, 01 Oct 2026 13:00:00 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/vaccines-or-murder-the-andrea-shaw-case-puts-medical-freedom-advocacyand-the-mediaon-trial-442e5a50" title="Vaccines or Murder? The Andrea Shaw Case Puts Medical-Freedom Advocacy—and the Media—on Trial" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/ae37e93e-a0f8-4fe2-c7ae-c7cd71f6b100/public" loading="lazy" /></a> Vaccines or Murder? The Andrea Shaw Case Puts Medical-Freedom Advocacy—and the Media—on Trial]]></description>
        </item>
        <item>
            <title><![CDATA[Big Pharma’s $457 Million Washington Machine: Influence Hits Record Levels]]></title>
            <link>https://trialsitenews.com/p/trialsitenews/big-pharmas-457-million-washington-machine-influence-hits-record-levels-64986f10</link>
            <guid>https://trialsitenews.com/p/trialsitenews/big-pharmas-457-million-washington-machine-influence-hits-record-levels-64986f10</guid>
            <pubDate>Thu, 01 Oct 2026 03:07:17 GMT</pubDate>
            <description><![CDATA[<a href="https://trialsitenews.com/p/trialsitenews/big-pharmas-457-million-washington-machine-influence-hits-record-levels-64986f10" title="Big Pharma’s $457 Million Washington Machine: Influence Hits Record Levels" rel="nofollow"><img width="300" height="161" src="https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/d12e9f10-4e97-4fdc-9f3f-cc50c0a26900/public" loading="lazy" /></a> Big Pharma’s $457 Million Washington Machine: Influence Hits Record Levels]]></description>
        </item>
    </channel>
</rss>